HomeInsightsStock Comparison

Kk Shah Hospitals Ltd vs Syngene International Ltd Stock Comparison

Kk Shah Hospitals Ltd vs Syngene International Ltd Stock Comparison

Last Updated on: Jul 20, 2025

Key Highlights

  • The Latest Trading Price of KK Shah Hospitals Ltd is ₹ 43 as of 16 Jul 15:30.
  • The P/E Ratio of KK Shah Hospitals Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 23.5 on March 2020 to 58.9 on March 2025 . This represents a CAGR of 16.55% over 6 years.
  • The Market Cap of KK Shah Hospitals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 9662 crore on March 2020 to ₹ 29228 crore on March 2025 . This represents a CAGR of 20.26% over 6 years.
  • The revenue of KK Shah Hospitals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Mar '25 is ₹ 1036 crore as compare to the Dec '24 revenue of ₹ 962 crore. This represent the growth of 7.79%.
  • The ebitda of KK Shah Hospitals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Mar '25 is ₹ 362.5 crore as compare to the Dec '24 ebitda of ₹ 301.9 crore. This represent the growth of 20.07%.
  • The net profit of KK Shah Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Syngene International Ltd changed from ₹ 93.4 crore to ₹ 183.3 crore over 8 quarters. This represents a CAGR of 40.09% .
  • The Dividend Payout of KK Shah Hospitals Ltd changed from 55.82 % on March 2024 to 0 % on February 2023 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 0 % on February 2023 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About KK Shah Hospitals Ltd

  • KK Shah Hospitals Limited was incorporated under the name style of 'Jeevan Parv Healthcare Limited' on August 25, 2022 by the Central Registration Center, Manesar.
  • Subsequently, the Company changed its name from 'Jeevan Parv Healthcare Limited' to 'KK Shah Hospitals Limited' vide a fresh certificate of incorporation on November 30, 2022 issued by the Registrar of Companies, Gwalior, Madhya Pradesh.
  • The Company at present is engaged in the providing healthcare services. The Promoter, Dr. Kirti Kumar Shah started a clinic in Ratlam city in the year 1976 which further was transformed into a nursing home in the year 1991.
  • Subsequently, Dr. Kirti Kumar Shah established pediatrics care unit in 1991 under the name of 'Shah Maternity and Nursing Home'.
  • He started paediatric unit having Neonatal Intensive Care Unit (NICU) as an integral part of the Clinic in 1994.

About Syngene International Ltd

  • Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
  • Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
  • The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
  • The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
  • The Company's health-related services extend across all major therapeutic areas and modalities.

KK Shah Hospitals Ltd News Hub

News

KK Shah Hospitals schedules board meeting

KK Shah Hospitals will hold a meeting of the Board of Directors of the Company on 27 May 2...

Read more

19 May 2025 12:03

News

KK Shah Hospitals to conduct board meeting

KK Shah Hospitals will hold a meeting of the Board of Directors of the Company on 12 Novem...

Read more

06 Nov 2024 16:05

News

KK Shah Hospitals schedules AGM

KK Shah Hospitals announced that the 2nd Annual General Meeting (AGM) of the company will ...

Read more

30 Jul 2024 17:46

News

Board of KK Shah Hospitals recommends final dividend

KK Shah Hospitals announced that the Board of Directors of the Company at its meeting held...

Read more

28 May 2024 16:37

News

KK Shah Hospitals declare Quarterly Result

KK Shah Hospitals will hold a meeting of the Board of Directors of the Company on 28 May 2...

Read more

17 May 2024 12:38

News

KK Shah Hospitals to conduct board meeting

KK Shah Hospitals will hold a meeting of the Board of Directors of the Company on 7 Decemb...

Read more

04 Dec 2023 10:42

Syngene International Ltd News Hub

News

Syngene International declare Quarterly Result

Syngene International will hold a meeting of the Board of Directors of the Company on 23 J...

Read more

12 Jul 2025 10:08

News

Syngene's Bengaluru-based facility gets 'NAi' status from US FDA

The inspection concluded successfully, with the facility found to be in compliance with th...

Read more

14 Jun 2025 14:28

News

Syngene International to conduct AGM

Syngene International announced that the 32nd Annual General Meeting(AGM) of the company w...

Read more

24 Apr 2025 11:30

News

Board of Syngene International recommends final dividend

Syngene International announced that the Board of Directors of the Company at its meeting ...

Read more

24 Apr 2025 10:43

News

Volumes spurt at Syngene International Ltd counter

Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceutic...

Read more

24 Apr 2025 14:30

News

Syngene International Ltd leads losers in 'A' group

Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other...

Read more

24 Apr 2025 15:00

SWOT Analysis Of Syngene International Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Syngene International Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for KK Shah Hospitals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of KK Shah Hospitals Ltd and Syngene International Ltd

Which company has a larger market capitalization, KK Shah Hospitals Ltd or Syngene International Ltd?

Market cap of KK Shah Hospitals Ltd is 29 Cr while Market cap of Syngene International Ltd is 26,487 Cr

What are the key factors driving the stock performance of KK Shah Hospitals Ltd and Syngene International Ltd?

The stock performance of KK Shah Hospitals Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KK Shah Hospitals Ltd and Syngene International Ltd?

As of July 20, 2025, the KK Shah Hospitals Ltd stock price is INR ₹43.0. On the other hand, Syngene International Ltd stock price is INR ₹657.35.

How do dividend payouts of KK Shah Hospitals Ltd and Syngene International Ltd compare?

To compare the dividend payouts of KK Shah Hospitals Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions